Literature DB >> 15184677

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

Daniel R Rhodes1, Jianjun Yu, K Shanker, Nandan Deshpande, Radhika Varambally, Debashis Ghosh, Terrence Barrette, Akhilesh Pandey, Arul M Chinnaiyan.   

Abstract

Many studies have used DNA microarrays to identify the gene expression signatures of human cancer, yet the critical features of these often unmanageably large signatures remain elusive. To address this, we developed a statistical method, comparative metaprofiling, which identifies and assesses the intersection of multiple gene expression signatures from a diverse collection of microarray data sets. We collected and analyzed 40 published cancer microarray data sets, comprising 38 million gene expression measurements from >3,700 cancer samples. From this, we characterized a common transcriptional profile that is universally activated in most cancer types relative to the normal tissues from which they arose, likely reflecting essential transcriptional features of neoplastic transformation. In addition, we characterized a transcriptional profile that is commonly activated in various types of undifferentiated cancer, suggesting common molecular mechanisms by which cancer cells progress and avoid differentiation. Finally, we validated these transcriptional profiles on independent data sets.

Entities:  

Mesh:

Year:  2004        PMID: 15184677      PMCID: PMC438973          DOI: 10.1073/pnas.0401994101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

2.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

3.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

4.  Gene expression analysis of prostate cancers.

Authors:  Jian-Hua Luo; Yan Ping Yu; Kathleen Cieply; Fan Lin; Petrina Deflavia; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich
Journal:  Mol Carcinog       Date:  2002-01       Impact factor: 4.784

Review 5.  Proteasome inhibitors as new anticancer drugs.

Authors:  Julian Adams
Journal:  Curr Opin Oncol       Date:  2002-11       Impact factor: 3.645

6.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

7.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

8.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Authors:  Henry F Frierson; Adel K El-Naggar; John B Welsh; Lisa M Sapinoso; Andrew I Su; Jun Cheng; Takashi Saku; Christopher A Moskaluk; Garret M Hampton
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Authors:  Donald R Schwartz; Sharon L R Kardia; Kerby A Shedden; Rork Kuick; George Michailidis; Jeremy M G Taylor; David E Misek; Rong Wu; Yali Zhai; Danielle M Darrah; Heather Reed; Lora H Ellenson; Thomas J Giordano; Eric R Fearon; Samir M Hanash; Kathleen R Cho
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

Authors:  Eva LaTulippe; Jaya Satagopan; Alex Smith; Howard Scher; Peter Scardino; Victor Reuter; William L Gerald
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  418 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Sortilin regulates progranulin action in castration-resistant prostate cancer cells.

Authors:  Ryuta Tanimoto; Alaide Morcavallo; Mario Terracciano; Shi-Qiong Xu; Manuela Stefanello; Simone Buraschi; Kuojung G Lu; Demetrius H Bagley; Leonard G Gomella; Katia Scotlandi; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

3.  Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.

Authors:  Somsubhra Nath; Abhishek Chowdhury; Sanjib Dey; Anirban Roychoudhury; Abira Ganguly; Dibyendu Bhattacharyya; Susanta Roychoudhury
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

4.  PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.

Authors:  Matteo Fassan; Marco Pizzi; Luciano Giacomelli; Claudia Mescoli; Kathrin Ludwig; Salvatore Pucciarelli; Massimo Rugge
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

5.  An empirical Bayes' approach to joint analysis of multiple microarray gene expression studies.

Authors:  Lingyan Ruan; Ming Yuan
Journal:  Biometrics       Date:  2011-04-22       Impact factor: 2.571

6.  Identification of cancer genomic markers via integrative sparse boosting.

Authors:  Yuan Huang; Jian Huang; Ben-Chang Shia; Shuangge Ma
Journal:  Biostatistics       Date:  2011-10-31       Impact factor: 5.899

7.  Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

Authors:  Giada Monami; Velia Emiliozzi; Alessandro Bitto; Francesca Lovat; Shi-Qiong Xu; Silvia Goldoni; Matteo Fassan; Ginette Serrero; Leonard G Gomella; Raffaele Baffa; Renato V Iozzo; Andrea Morrione
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations.

Authors:  Johanna W Lampe; Sandi L Navarro; Meredith A J Hullar; Ali Shojaie
Journal:  Proc Nutr Soc       Date:  2013-02-06       Impact factor: 6.297

9.  The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.

Authors:  Donato Tedesco; Jianhuan Zhang; Lan Trinh; Guita Lalehzadeh; Rene Meisner; Ken D Yamaguchi; Daniel L Ruderman; Harald Dinter; Deborah A Zajchowski
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

10.  Celsius: a community resource for Affymetrix microarray data.

Authors:  Allen Day; Marc R J Carlson; Jun Dong; Brian D O'Connor; Stanley F Nelson
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.